Results 161 to 170 of about 1,137,562 (341)

Trends in Smoldering Myeloma Incidence in the United States From Cancer Registries, 2012–2022

American Journal of Hematology, EarlyView.
Rong Wang, Amy J. Davidoff, Martin Schoen, John H. Huber, Eric J. Feuer, Jennifer Ruhl, Natalia Neparidze, Xiaomei Ma, Su‐Hsin Chang, Shi‐Yi Wang   +9 more
wiley   +1 more source

Clot Composition Profiling in Large Vessel Occlusion Stroke Via Radiomics

Annals of Neurology, EarlyView.
Objective Clot composition may offer insights into the mechanism of ischemic stroke. Radiomics, a noninvasive imaging technique, enables tissue characterization through radiomic features (RFs). We aimed to evaluate clot composition using radiomics on non‐contrast computed tomography (NCCT).
Andres Gudino, Elena Sagues, Carlos Dier, Diego Ojeda, Samantha Saenz‐Hinojosa, Sebastian Sanchez, Ariel Vargas, Linder Wendt, Maria Belen Torres, Emily Garces, Alex Hanson, Navami Shenoy, Connor Aamot, Susan A. Walsh, Anil K. Chauhan, Gowri Anil‐Peethambar, Santiago Ortega‐Gutierrez, Jay Kinariwala, Mohamed Elshikh, Amir Shaban, Enrique C. Leira, Osorio Lopes Abath Neto, Malik Ghannam, Edgar A. Samaniego   +23 more
wiley   +1 more source

Responsiveness to City Service Requests, Life Satisfaction, and Horizontal Inequality: Does Good Local Governance Improve Subjective Well-Being for All? [PDF]

Int J Environ Res Public Health
Tharakan DPL, Ford TN.
europepmc   +1 more source

December 5th 2001 [PDF]

, 2001
Hispanic News
core  

A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis

Arthritis &Rheumatology, Accepted Article.
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane, Christopher C. Striebich, Marie L. Feser, James R. O'Dell, Judith A. James, Jeffrey A. Sparks, John M. Davis, Jonathan Graf, Maureen A. McMahon, Elizabeth B. Solow, Lindsy Forbess, Athan Tiliakos, Elena Schiopu, Maria I. Danila, Diane L. Horowitz, Jonathan Kay, Colin D. Strickland, Joel M. Guthridge, Cristina Arriens, Jennifer M. Grossman, M. Kristen Demoruelle, Elizabeth A. Bemis, Ashley Frazer‐Abel, Chelsie L. Fleischer, David A. Fox, Ted R. Mikuls, Melissa Greenleaf, Kate York, Sarah Walker, Lynette Keyes‐Elstein, Margie Byron, Janel Fedler, Ellen A. Goldmuntz, V. Michael Holers   +33 more
wiley   +1 more source

Progression of immunoglobulin A nephropathy (IgAN) in a Hispanic/Latinx population in the United States. [PDF]

Front Nephrol
Sim JJ, Cannizzaro NT, Chen Q, Nunna S, Mathur M, Pinto C.   +5 more
europepmc   +1 more source

March 12th 2003 [PDF]

, 2003
Hispanic News
core  

The Hispanic paradox [PDF]

The Lancet, 2015
openaire   +2 more sources

Pulmonary Disease and Age at Immigration among Hispanics. Results from the Hispanic Community Health Study/Study of Latinos.

American Journal of Respiratory and Critical Care Medicine, 2016
R. Barr, Larissa M Avilés-Santa, Sonia M. Davis, Tom K. Aldrich, F. Gonzalez, Ashley G. Henderson, R. Kaplan, L. LaVange, Kiang Liu, J. Loredo, Eliana S. Mendes, A. Ni, A. Ries, M. Salathe, Lewis J. Smith   +14 more
semanticscholar   +1 more source

A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus

Arthritis &Rheumatology, EarlyView.
Objective Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus erythematosus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity, and incidence of SLE.
Nancy J. Olsen, Duanping Liao, Judith A. James, Joel M. Guthridge, Cristina Arriens, Diane Kamen, Mariko Ishimori, Daniel J. Wallace, Christopher Striebich, Sonali Narain, Benjamin F. Chong, Fan He, Eric W. Schaefer, Vernon M. Chinchilli, David R. Karp   +14 more
wiley   +1 more source